Please login to the form below

Not currently logged in
Email:
Password:

Juno Therapeutics names Cindy Elkins as CIO

She joins the biopharma from Genentech, where she was VP of IT

Cindy Elkins has joined Juno Therapeutics - now a part of Celgene - as its new chief information officer, a role that will see her report directly to Hans Bishop, Juno’s president and chief executive officer.

He said: “Cindy is a leader with a track record of increasing the impact of information technology in the biotech industry, focusing on innovation and delivering advanced technologies that support the discovery of breakthrough therapies.

“Her talent, passion and experience will help us advance our mission to bring better medicines to patients.”

Elkins most recently served as vice president, IT for the Americas at Genentech, where she led its US commercial technology integration following the firm's acquisition by Roche.

She said: “I am delighted to join Juno, a company that reflects my passion for vibrant, accountable, high-performing organisations seeking to transform and innovate at scale.

“It is an honour to be a part of a mission to fundamentally change the way cancer and other diseases are treated, and to provide the tools and infrastructure to allow Juno’s employees to do their best work.”

7th February 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics